In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci

PURPOSE: The emergence of vancomycin resistant Enterococci (VRE) is shortening the choices for clinical anti-infective therapy. The aim of this study was to investigate the mechanism of vancomycin resistance and evaluate the effect of fosfomycin (FM), rifampin (RIF), vancomycin (VAN), linezolid (LNZ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drug Des Devel Ther
Autores principales: Tong, Jiepeng, Jiang, Yiheng, Xu, Hao, Jin, Xuehang, Zhang, Li, Ying, Shuaibing, Yu, Wei, Qiu, Yunqing
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285921/
https://ncbi.nlm.nih.gov/pubmed/34285472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S315061
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares